主论坛嘉宾议程公开 | 2025（第五届）类器官大会，3月7-8日上海开幕！

新西兰皇家科学院                                  

Prof. Peter E. Lobie is a Fellow (Academician) of the Royal Society of New Zealand, as well as a Professor and Director of the Precision Medicine and Healthcare Research Center at the Tsinghua-Berkeley Shenzhen Institute (TBSI). Prof. Lobie is the founding chairman of the ISoOR. 

He has dedicated years to the study of targeted therapy for cancer and has conducted pioneering research on factors leading to tumor development. He is the author of over 190 publications and an international authority on the molecular mechanisms of hormone action, with more than 9,000 citations and an h-factor of 53. Prof. Lobie holds over 28 international patents, has secured 24 national-level research funds, and has been financed for project development by internationally renowned academic institutions such as the National Research Foundation of Singapore and the Royal Society of New Zealand. 

Additionally, he is the recipient of the Chinese Government Friendship Award, which is the highest honor given to foreigners from the People's Republic of China.

上海交通大学医学院附属新华医院

上海大学转化医学研究院                          

苏佳灿，主任医师、教授、博导，上海交通大学医学院附属新华医院骨科主任、运动系统损伤与类器官转化医学研究所所长，国家转化医学中心（上海）生物材料与医疗器械中心主任，教育部“长江学者”特聘教授，国家卫健委科普库专家，上海市高水平地方高校重点创新团队负责人，福建“闽江学者”，科技部重点研发首席科学家、国防科技创新特区重点项目首席科学家。

上海交通大学医学院附属瑞金医院                      

教授/博导，上海交通大学医学院附属瑞金医院/上海市伤骨科研究所。主要从事再生医学材料研究，并促进临床转化，发表论文100余篇， H=64，引用1.4万余次，专利70项（转化13项）、主编Elsevier/Wiley书2本等。入选全球高被引学者、ESI高被引论文、全球前2%顶尖科学家、英国皇家化学学会会士（FRSC）、中国生物材料学会理事（FCSB）、教育部高等学校科学研究优秀成果奖和上海市科技进步一等奖、全国转化医学创新奖等。主持国家自然科学基金重点项目、国家重点研发课题、国家级青年人才项目、上海市科委和卫健委优秀学带等项目。

ISoOR                   

Dr. Martin Maldonado is an Argentine scientist who graduated in Physical Education Sciences at the Universidad Nacional de Rio Cuarto, Argentina in 2002 and received a Master's degree in Exercise Physiology at the Universidad Federal de Santa Maria, Brazil in 2004. In 2010 he earned his doctorate in Medicine from Ehime University, Japan. Then, he conducted research in the field of neuropharmacology for several years in the same country. 

In 2013 Dr. Maldonado moved to China where he initially worked as a postdoctoral fellowship in the field of stem cells, at Shantou University, Guangdong, China. He investigated the potential of human Umbillical Mesenchymal Stem Cells (hUMSCs) stem cell’s therapy for diabetes type 2 treatment. 

Later on, Dr. Maldonado moved to the city of Chengdu where he continued stem cell research as a long-term associate researcher at an institute of Reproductive Medicine & Genetics. He established a stem cells facility and leaded a research team who evaluated how the differentiation potential of hUMSCs and paracrine signaling interaction contribute to improving the in vitro maturation of mouse cumulus-oocyte complexes (mCOCs). Moreover, his team produced several SCI publications in the field of stem cells and anti-aging. 

Thereafter, Dr. Maldonado worked as a Research Manager in the field of organoids research in the pharmaceutical industry. His research achievements are published in SCI journals like AGING, Stem Cells International, Cell Communication and Signalling, Neurochemistry International, and the International Journal of Nanomedicine, among others.

上海交通大学医学院附属仁济医院                                                   

上海交通大学医学院附属仁济医院临床干细胞中心PI、研究员和博导，并担任癌基因与相关基因国家重点实验室研究组组长及仁济泌尿外科兼职教授；现为上海市高层次人才项目入选者、东方学者及医学院“双百人”。于2002获得Universiti Kebangsaan Malaysia生物医学学士；2009年取得香港大学癌症生物学博士；2009至2017年，在美国哥伦比亚大学医学中心先后进行博士后训练及担任副研究员。

在博士后期间，利用前列腺癌基因工程小鼠模型，重点探究雄激素受体（AR）在前列腺上皮管腔细胞的作用机制；此课题获得美国国防部前列腺癌研究计划博士后研究基金的资助，及美国癌症研究协会Scholar-in-Training奖。此外，成功建立一种全新的类器官培养系统，用于长期体外培养前列腺管腔祖细胞、前列腺和膀胱癌。这些研究成果已发表在国际顶尖杂志，如Nature Cell Biology, eLife和Cell，并获得国际专利2项。

作为类器官培养系统的发明者，获邀在Cold Spring Harbor Laboratory举办的首届“The Organotypic and Next Generation Culture”工作坊担任实验导师，教授来自世界各国的青年学者有关类器官的培养方法。同时，作为eLife Community Ambassador，致力推动发展中国家青年科学家的职业培训项目。课题组先后获得国家自然科学基金面上项目2项、青年项目1项，以及上海市科委“一带一路”国际合作项目1项。